Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market

Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market Outlook 2035

• The Africa hyperbaric oxygen therapy (HBOT) devices industry was valued at US$ 50.83 Mn in 2024
• It is projected to grow at a CAGR of 5.1% from 2025 to 2035 and cross US$ 88.64 Mn by the end of 2035

Analysts’ Viewpoint

The Hyperbaric Oxygen Therapy (HBOT) Devices Market is expected to grow steadily with many factors fueling growth. Primarily is the growing burden worldwide of chronic wounds, diabetic ulcers, and post-operative complications, and increasing understanding among clinicians and patients of the therapeutic uses of HBOT to heal wounds, treat decompression sickness, and some neurological disorders. The growing aging population combined with the growing prevalence of diabetes will also drive demand for HBOT devices.

Ongoing investments in healthcare infrastructure and, more favorably, access to reimbursement for HBOT services in the US and some parts of Europe will drive growth.The availability of HBOT devices is limited, and the global market faces some significant restrictions including high costs for advanced HBOT devices, stringent regulation, need for specialized training and maintenance which especially limits adoption in lower resource settings or emerging markets which have more constrained healthcare spending.

The reimbursement policies vary, and there are, in some instances, the absence of standardized protocols can be limiting to market access. With the pace of technology innovation, the market has numerous opportunities including a trend towards portability and at-home HBOT, artificial intelligence and IoT, and the development of applications that will offer wearable hyperbaric solutions with a view to at-home care and improved access for more patients

Market Introduction

HBOT (hyperbaric oxygen therapy) devices (hyperbaric chambers) are specialized medical devices that provide pure oxygen to patients at increased atmospheric pressure. HBOT devices increase the blood's carrying capacity of oxygen, which allows oxygen to more easily reach the tissues and organs. HBOT devices can be viewed as rooms or tubes (monoplace or multiplace chambers) operated at increased environmental pressure (~higher than 1 atmosphere of absolute pressure, or ATA) to deliver 100% oxygen to a patient.

The pressure in the chamber is higher than normal atmospheric pressure (greater than 1 ATA). Under the increased pressure environment, the person's lungs can absorb more oxygen, and the blood carries it throughout the body.

Government Initiatives and Support Anticipated to Boost Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market Share

Government initiatives and support are expected to propel the growth of Africa Hyperbaric Oxygen Therapy (HBOT) devices market. Across the continent, governments are increasingly recognizing the importance of wound care solutions, especially in the treatment of chronic diseases such as diabetic foot ulcers, radiation injury, and non-healing wounds.

With increased prevalence of diabetes and the other chronic diseases, public health stakeholders are turning their attention toward integrating HBOT into national health policy to address the growing clinical burden.

One of the primary ways government support is propelling market growth is through direct investment in healthcare infrastructure. Some African countries are investing in the upgradation of public hospitals with high-technology HBOT chambers, hence making the treatments affordable to a major percentage of the population

This is particularly notable where private medicine is unaffordable and the public hospitals remain the hub of high-tech medical care. By placing HBOT units within government hospitals, the authorities are not only giving better results but also generating procedural volume as well as growing the market share for the device manufacturers

For instance, in December 2023, Tanzania became the first country in the East African region and the second in Sub-Saharan Africa to acquire a Hyperbaric Oxygen Therapy machine. The instrument was officially launched at Muhimbili National Hospital (MNH) in the country’s business hub

Moreover, in August 2021, The Kogi State Government procured the first hospital based Hyperbaric Oxygen Treatment (HBOT) chamber in Nigeria. With this development, Nigeria becomes the fifth country in Africa with such sophisticated medical equipment.

This milestone underscores the government's commitment to advancing healthcare infrastructure and improving patient care through the adoption of advanced medical technologies

Growing healthcare expenditure to Drive Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market Expansion

Increased healthcare spending in Africa is expected to boost the growth of Hyperbaric Oxygen Therapy (HBOT) device market. The prosperity of African countries is accompanied by increasing spending on healthcare, which subsequently fuels improved healthcare infrastructure and increased investment in sophisticated medical technology.

According to data published by national treasury budge review of South Africa, health spending is set to increase from US$ 15.6 Billion (R277 Bn) in 2024/25 to US$ 18.5 Billion (R329 Bn) in 2027/28 to support public health services, including free primary healthcare.

This growing spending enables medical facilities to invest in advanced equipment such as HBOT units, which play a core role in the cure of most chronic diseases such as diabetic foot wounds, cardiovascular disease, and long-standing wounds.

Moreover, addition of HBOT to the national health insurance packages is making the treatment accessible to a larger population, thus further fueling demand.

This trend is specifically notable for nations with an increasing rate of chronic conditions where there is greater demand for new and effective therapies to manage the health issues Monoplace HBOT devices

Leading Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market

Monoplace HBOT devices are the leading by product segment of the Africa hyperbaric oxygen therapy devices market based on their compact size and usage at outpatient centers. Occupation of a single chamber is efficient in curing conditions such as decompression sickness and wounds.

The rising awareness of the advantages of hyperbaric therapy and improved access to healthcare facilities providing these treatments have fueled demand for monoplace devices. Their capacity to provide controlled oxygen therapy safely positions them in a position of preference, ensuring that they maintain dominant role in the expanding market

Regional Outlook of Hyperbaric Oxygen Therapy (HBOT) Devices Market

South Africa is the leading country in the Africa hyperbaric oxygen therapy devices market due to its well-established healthcare system and regulatory structures, and advanced medical technology in the continent.

More awareness around the advantages of hyperbaric oxygen therapy within the country has seen a larger pool of specialised clinics and hospitals providing hyperbaric oxygen therapy services. There is also a prevalence of chronic conditions such as diabetes and related wounds increasing the demand for viable treatment alternatives like hyperbaric oxygen therapy.

These collective features allow South Africa to play a prominent role in the market to ensure access to advanced healthcare delivery across the continent

Analysis of Key Players in Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market

Leading players within the Africa Hyperbaric Oxygen Therapy (HBOT) Devices industry are concentrating on investment in intelligent technology for Hyperbaric Oxygen Therapy (HBOT) Devices. The makers are also giving emphasis to sustainability through the use of environmentally friendly materials and minimizing packaging waste, reflecting global trends towards environmental consciousness.

Sechrist Industries, OxyHealth, HAUX-LIFE-SUPPORT GmbH, Perry Baromedical, SolidO2, Unique Group, Biobarica. Shenyang Canta Medical Tech. Co., Ltd., and Global Wellness Enterprises are some of the leading players operating in the Africa Hyperbaric Oxygen Therapy (HBOT) Devices market.

Each of these players have been have been profiled in the Hyperbaric Oxygen Therapy (HBOT) Devices market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Hyperbaric Oxygen Therapy (HBOT) Devices Market

• In May 2025, OxyHealth, the exclusive provider of world-class hyperbaric oxygen chambers for iCRYO, announced its participation in Dave Asprey's 2025 Biohacking Conference. The conference, which took place in May 28-30, 2025 in Austin, TX, U.S., brought together top innovators, researchers, and wellness pioneers dedicated to optimizing human performance, longevity, and overall well-being. OxyHealth is excited to connect further with the biohacking community and demonstrate how hyperbaric oxygen therapy is integral to the future of health and performance
• In April 2025, Biobarica presents the new update of the Biobarica Global System (BGS), a comprehensive management software designed to optimize the administration of hyperbaric treatment with the Revitalair 430 chamber. This version incorporates a more intuitive interface and new functionalities that improve clinical organization, optimize resources and favor patient follow-up

Hyperbaric Oxygen Therapy (HBOT) Devices Market Snapshot